Medical Market Report

Global Radiopharmaceutical Market By Type (Actinium-225, Lutetium-177, Radium-223, and Holmium-166), By Application (Oncology, and Cardiology), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 134684
  • 12-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Radiopharmaceutical Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global radiopharmaceutical market is segmented on the basis of Type, Application, and geography.
    The global Radiopharmaceutical market was valued at US$ XX.X Mn in 2018 and is projected to increase significantly at a CAGR of x.x% from 2019 to 2028.

    Radiopharmaceutical Market Scope:

    By type, the market is segmented into Actinium-225, Lutetium-177, Radium-223, and Holmium-166. By Application, the market is divided into Oncology, and Cardiology. Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Bracco Imaging, Bayer, Mallinckrodt, Nordion, Triad Isotopes, Lantheus, IBA Group, GE Healthcare, China Isotope & Radiation, Jubilant Pharma, Eli Lilly, Advanced Accelerators, SIEMENS, Dongcheng, and Navidea.

    Key Market Segments

    Type

    Actinium-225
    Lutetium-177
    Radium-223
    Holmium-166

    Application

    Oncology
    Cardiology

    Key Market Players included in the report:

    Bracco Imaging
    Bayer
    Mallinckrodt
    Nordion
    Triad Isotopes
    Lantheus
    IBA Group
    GE Healthcare
    China Isotope & Radiation
    Jubilant Pharma
    Eli Lilly
    Advanced Accelerators
    SIEMENS
    Dongcheng
    Navidea

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Radiopharmaceutical Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape. Emerging and high-growth sections of Radiopharmaceutical Market, high-growth regions, and market drivers, restraints, and also market chances.
    The analysis covers Radiopharmaceutical Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Radiopharmaceutical Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Radiopharmaceutical Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Radiopharmaceutical Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Radiopharmaceutical sub-markets, depending on key regions (various vital states).
    To analyze Radiopharmaceutical Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Radiopharmaceutical Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Radiopharmaceutical Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Radiopharmaceutical Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

    2.1. Key Findings by Major Segments
    
2.2. Top strategies by Major Players3. Global Radiopharmaceutical Market Overview
    

    3.1. Radiopharmaceutical Market Dynamics
    

    3.1.1. Drivers
    
3.1.2. Opportunities
    
3.1.3. Restraints
    
3.1.4. Challenges3.2. PESTLE Analysis
    
3.3. Opportunity Map Analysis
    
3.4. PORTER’S Five Forces Analysis
    
3.5. Market Competition Scenario Analysis
    
3.6. Product Life Cycle Analysis
    
3.7. Opportunity Orbits
    
3.8. Manufacturer Intensity Map4. Global Radiopharmaceutical Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

    4.1. Global Radiopharmaceutical Market Analysis by Type: Introduction
    
4.2. Market Size and Forecast by Region
    
4.3. Actinium-225
    
4.4. Lutetium-177
    
4.5. Radium-223
    
4.6. Holmium-1665. Global Radiopharmaceutical Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

    5.1. Global Radiopharmaceutical Market Analysis by Application: Introduction
    
5.2. Market Size and Forecast by Region
    
5.3. Oncology
    
5.4. Cardiology6. Global Radiopharmaceutical Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

    6.1. North America
    

    6.1.1. North America Radiopharmaceutical Market: Regional Trend Analysis
    

    6.1.1.1. US
    
6.1.1.2. Canada
    
6.1.1.3. Mexico
    

    6.2. Europe
    

    6.2.1. Europe Radiopharmaceutical Market: Regional Trend Analysis
    

    6.2.1.1. Germany
    
6.2.1.2. France
    
6.2.1.3. UK
    
6.2.1.4. Russia
    
6.2.1.5. Italy
    
6.2.1.6. Rest of Europe
    

    6.3. Asia-Pacific
    

    6.3.1. Asia-Pacific Radiopharmaceutical Market: Regional Trend Analysis
    

    6.3.1.1. China
    
6.3.1.2. Japan
    
6.3.1.3. Korea
    
6.3.1.4. India
    
6.3.1.5. Rest of Asia
    

    6.4. Latin America
    

    6.4.1. Latin America Radiopharmaceutical Market: Regional Trend Analysis
    

    6.4.1.1. Brazil
    
6.4.1.2. Argentina
    
6.4.1.3. Rest of Latin America
    

    6.5. Middle East and Africa
    

    6.5.1. Middle East and Africa Radiopharmaceutical Market: Regional Trend Analysis
    

    6.5.1.1. GCC
    
6.5.1.2. South Africa
    
6.5.1.3. Israel
    
6.5.1.4. Rest of MEA
    
7. Global Radiopharmaceutical Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

    7.1. Market Share Analysis
    
7.2. Company Profiles
    
7.3. Bracco Imaging
    

    7.3.1. Company Overview
    
7.3.2. Financial Highlights
    
7.3.3. Product Portfolio
    
7.3.4. SWOT Analysis
    
7.3.5. Key Strategies and Developments7.4. Bayer
    

    7.4.1. Company Overview
    
7.4.2. Financial Highlights
    
7.4.3. Product Portfolio
    
7.4.4. SWOT Analysis
    
7.4.5. Key Strategies and Developments7.5. Mallinckrodt
    

    7.5.1. Company Overview
    
7.5.2. Financial Highlights
    
7.5.3. Product Portfolio
    
7.5.4. SWOT Analysis
    
7.5.5. Key Strategies and Developments7.6. Nordion
    

    7.6.1. Company Overview
    
7.6.2. Financial Highlights
    
7.6.3. Product Portfolio
    
7.6.4. SWOT Analysis
    
7.6.5. Key Strategies and Developments7.7. Triad Isotopes
    

    7.7.1. Company Overview
    
7.7.2. Financial Highlights
    
7.7.3. Product Portfolio
    
7.7.4. SWOT Analysis
    
7.7.5. Key Strategies and Developments7.8. Lantheus
    

    7.8.1. Company Overview
    
7.8.2. Financial Highlights
    
7.8.3. Product Portfolio
    
7.8.4. SWOT Analysis
    
7.8.5. Key Strategies and Developments7.9. IBA Group
    

    7.9.1. Company Overview
    
7.9.2. Financial Highlights
    
7.9.3. Product Portfolio
    
7.9.4. SWOT Analysis
    
7.9.5. Key Strategies and Developments7.10. GE Healthcare
    

    7.10.1. Company Overview
    
7.10.2. Financial Highlights
    
7.10.3. Product Portfolio
    
7.10.4. SWOT Analysis
    
7.10.5. Key Strategies and Developments7.11. China Isotope & Radiation
    

    7.11.1. Company Overview
    
7.11.2. Financial Highlights
    
7.11.3. Product Portfolio
    
7.11.4. SWOT Analysis
    
7.11.5. Key Strategies and Developments7.12. Jubilant Pharma
    

    7.12.1. Company Overview
    
7.12.2. Financial Highlights
    
7.12.3. Product Portfolio
    
7.12.4. SWOT Analysis
    
7.12.5. Key Strategies and Developments7.13. Eli Lilly
    

    7.13.1. Company Overview
    
7.13.2. Financial Highlights
    
7.13.3. Product Portfolio
    
7.13.4. SWOT Analysis
    
7.13.5. Key Strategies and Developments7.14. Advanced Accelerator Applications
    

    7.14.1. Company Overview
    
7.14.2. Financial Highlights
    
7.14.3. Product Portfolio
    
7.14.4. SWOT Analysis
    
7.14.5. Key Strategies and Developments7.15. SIEMENS
    

    7.15.1. Company Overview
    
7.15.2. Financial Highlights
    
7.15.3. Product Portfolio
    
7.15.4. SWOT Analysis
    
7.15.5. Key Strategies and Developments7.16. Dongcheng
    

    7.16.1. Company Overview
    
7.16.2. Financial Highlights
    
7.16.3. Product Portfolio
    
7.16.4. SWOT Analysis
    
7.16.5. Key Strategies and Developments7.17. Navidea
    

    7.17.1. Company Overview
    
7.17.2. Financial Highlights
    
7.17.3. Product Portfolio
    
7.17.4. SWOT Analysis
    
7.17.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.